Constantine Kreatsoulas

Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors.

Michael Reilly, Laura Sepp-Lorenzino, Weikang Tao, 2006, Bioorganic & medicinal chemistry letters.

3-(Indol-2-yl)indazoles as Chek1 kinase inhibitors: Optimization of potency and selectivity via substitution at C6.

Lawrence C Kuo, Laura Sepp-Lorenzino, Weikang Tao, 2006, Bioorganic & medicinal chemistry letters.

Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors.

Lawrence C Kuo, Laura Sepp-Lorenzino, Weikang Tao, 2007, Bioorganic & medicinal chemistry letters.

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.

Laura Sepp-Lorenzino, Weikang Tao, Youwei Yan, 2009, Bioorganic & medicinal chemistry letters.

Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation

Craig W. Lindsley, William J. Ray, Michelle Pearson, 2009, Proceedings of the National Academy of Sciences.

Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis

Regina Barzilay, Ola Engkvist, Tommi Jaakkola, 2020, Journal of medicinal chemistry.

Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates.

Laura Sepp-Lorenzino, S. Stirdivant, M. Ikuta, 2012, Bioorganic & medicinal chemistry letters.

Comparison of Topological, Shape, and Docking Methods in Virtual Screening.

Robert P. Sheridan, Christopher I. Bayly, Vladimir N. Maiorov, 2007 .